Analyst Ratings for Immunovant (IMVT)
IMVT Rating Summary
IMVT Price Target Summary
- Highest: $62.00 (Guggenheim)
- Lowest: $30.00 (Truist Securities)
- Average: $44.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.75 (+11.2%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
Avg. $ Target:
$44.75 (+11.2%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/19/2026 | Bernstein SocGen Group » Updated 5/21/2026 |
William Pickering | New Coverage | Market Perform (N/A) |
35.00 (28.00) |
23.60 (40.26) |
70.59% | Details |
| 1/6/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
50.00 (N/A) |
397.83 (40.26) |
-89.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
